Search for: "Janssen Pharmaceuticals Inc."
Results 101 - 120
of 247
Sort by Relevance
|
Sort by Date
24 Nov 2014, 2:15 pm
Recently Revised Topamax Label Includes Data Of 2014 Annual Report From The North American Antiepileptic Drug (NAAED) Pregnancy Registry (Posted by Tom Lamb at DrugInjuryWatch.com) By means of an October 21, 2014 FDA letter to Janssen Pharmaceuticals, Inc. [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
24 Oct 2014, 7:56 am
Janssen Pharmaceuticals, Inc., No. 3:12-oe-40003, 2014 U.S. [read post]
8 Sep 2014, 12:00 am
Last month, the firm announced it had received $20 million (see here and here) from Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. [read post]
10 Jul 2014, 10:00 pm
Janssen Biotech, Inc. [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
9 Jun 2014, 4:51 am
Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. was the direct manufacturer maker of the Risperdal drug. [read post]
18 May 2014, 8:42 pm
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00594; filed May 12, 2014 in the District Court of Delaware • Plaintiffs: Alza Corp.; Janssen Pharmaceuticals Inc. [read post]
2 May 2014, 11:35 am
Janssen Pharmaceuticals, Inc., No. 3:12-oe-40003, 2014 U.S. [read post]
17 Apr 2014, 6:12 pm
Janssen Pharmaceutical Inc. agreed to the settlement without admitting to any wrongdoing, as part of a deal that prevents it from misleading consumers about its drugs in the future. [read post]
10 Apr 2014, 11:58 am
Janssen Pharmaceuticals, Inc., 2014 WL 1335511 (Pa. [read post]
10 Mar 2014, 11:31 am
Ortho-McNeil-Janssen Pharmaceuticals, 2013 WL 2917651, at *28 (Pa. [read post]
5 Mar 2014, 2:46 pm
Wyeth Pharmaceuticals, Inc., Pennsylvania Supreme Court – propriety of punitive damages where defendant compl [read post]
28 Feb 2014, 9:27 pm
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]
11 Feb 2014, 2:55 am
Janssen Pharm., Inc., No. 12-2132, 2014 U.S. [read post]
11 Feb 2014, 2:55 am
Janssen Pharm., Inc., No. 12-2132, 2014 U.S. [read post]
16 Jan 2014, 4:59 am
Inc. to pay $27.7 million related to the bone drug Fosamax. [read post]
14 Jan 2014, 5:39 am
Mutual Pharmaceutical Co., Inc. [read post]
30 Dec 2013, 5:25 am
Takeda Pharmaceutical Co. [read post]
29 Dec 2013, 9:15 pm
Janssen Pharmaceuticals Inc. et al. v. [read post]
